N
Patient 1
THE PATIENT RECEIVED AN OVER DOSAGE OF HEPARIN. STAFF INTERVENED WITH ADDITIONAL MEDICINE AND THE PATIENT RECOVERED WITH NO ADVERSE OUTCOME. HEPARIN IS USED TO TREAT AND PREVENT BLOOD CLOTS IN THE VEINS, ARTERIES, OR LUNG. IT IS ALSO USED BEFORE SURGERY TO REDUCE THE RISK OF BLOOD CLOTS. BLEEDING IS THE CHIEF SIGN OF HEPARIN OVER DOSAGE. NOSEBLEEDS, BLOOD IN URINE OR TARRY STOOLS MAY BE NOTED AS THE FIRST SIGN OF BLEEDING. EASY BRUISING OR PETECHIAL FORMATIONS MAY PRECEDE FRANK BLEEDING. IMMEDIATE TREATMENT TO REDUCE HEPARIN'S EFFECT MUST BE ADMINISTERED. HILL-ROM'S INVESTIGATION DETERMINED THE PREVIOUS PATIENT'S WEIGHT WAS SENT FOR THE CURRENT PATIENT. ANALYSIS OF THE (B)(6) NURSE CALL'S LOG FILES FOUND THAT FOR THE ROOM IN QUESTION, THE BED WEIGHT WAS NOT ZEROED AND A NEW WEIGHT WAS NOT CAPTURED PRIOR TO THE PATIENT BEING ADMITTED INTO THE NNC SYSTEM. ADDITIONALLY, THE SITE'S CONFIGURATION WAS FOR THE BED DATA, WHICH INCLUDES THE WEIGHT, TO REFRESH IMMEDIATELY ON PATIENT ADMISSION. THIS CONFIGURATION SETTING WAS MODIFIED SO THAT THE BED DATA WILL NOT REFRESH ON ADMIT. THIS WAS TESTED AND CONFIRMED TO OPERATE AS DESIRED WITH THE CUSTOMER. BASED ON THIS INFORMATION, NO FURTHER ACTION IS REQUIRED.